Robert Cyran, U.S. tech columnist, joined Breakingviews in London in 2003 and moved four years later to New York, where he continues to cover global technology, pharmaceuticals and special situations. Robert began his career at Forbes magazine, where he assisted in the startup of the international version of the magazine. Before working at Breakingviews he worked as a market researcher and reporter covering the pharmaceutical industry. Robert has a Masters degree in economics from Birmingham University and an undergraduate degree from George Washington University. Follow Rob on Twitter @rob_cyran
- Tel: +1 646 223 6083
- E-mail: firstname.lastname@example.org
Top venture-capital firms Andreessen Horowitz and Founders Fund each sold a roughly $60 mln stake in privately held car-hailing service Lyft to Saudi Prince Alwaleed. He and GM, meanwhile, invested more in the firm. They may regret going against the gathering traffic.
Three months after rival Perrigo refused its $26 bln offer, the drugmaker has agreed to buy Sweden’s Meda AB. Though the $7.2 bln transaction makes strategic sense, the 92 pct premium is hard to justify. Mylan might have been better served by trying to sell, rather than buy.
Bad practices led to CEO departures at Blackstone-backed mall owner Brixmor and HR software unicorn Zenefits. It’s a useful reminder of a Depression-era observation that good times mask bad behavior, but hard times expose it. These examples may be just a taste of what’s to come.
- Tech investors bear up for painful reality check
- Activist + private equity = no M&A for Symantec
- Amazon seeks brick hedges for click shipping costs
- Alphabet spells relief with R&D
- Express Scripts left vulnerable by contract spat
- Alere board's diligence brings 51 pct premium
- Amazon could eventually face a Xerox moment